Panmure Gordon Reiterates Hold Rating for GlaxoSmithKline (GSK)

Share on StockTwits

GlaxoSmithKline (LON:GSK)‘s stock had its “hold” rating reiterated by investment analysts at Panmure Gordon in a note issued to investors on Wednesday, Analyst Ratings Network.com reports. They currently have a GBX 1,750 ($28.73) price objective on the stock. Panmure Gordon’s price objective would indicate a potential upside of 5.33% from the stock’s previous close.

GlaxoSmithKline (LON:GSK) opened at 1659.4999 on Wednesday. GlaxoSmithKline has a 52 week low of GBX 1398.00 and a 52 week high of GBX 1816.00. The stock has a 50-day moving average of GBX 1599. and a 200-day moving average of GBX 1629.. The company’s market cap is £79.938 billion.

GSK has been the subject of a number of other recent research reports. Analysts at Credit Suisse reiterated an “underperform” rating on shares of GlaxoSmithKline in a research note to investors on Thursday, January 16th. They now have a GBX 1,500 ($24.62) price target on the stock. Separately, analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of GlaxoSmithKline in a research note to investors on Tuesday, January 14th. They now have a GBX 1,750 ($28.73) price target on the stock. Finally, analysts at UBS AG initiated coverage on shares of GlaxoSmithKline in a research note to investors on Friday, January 10th. They set a “neutral” rating on the stock. Five analysts have rated the stock with a sell rating, nine have issued a hold rating and nine have given a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of GBX 1,618.66 ($26.57).

GlaxoSmithKline plc (LON:GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Latest News

Citigroup Profit Beats Estimates
Citigroup Profit Beats Estimates
Dubai to Open New Six Flags Park in 2017
Dubai to Open New Six Flags Park in 2017
Source: FBI Probe Herbalife Marketing
Source: FBI Probe Herbalife Marketing
Ikea Investing in Illinois Wind Farm
Ikea Investing in Illinois Wind Farm
Stocks in China and Hong Kong Jump on Cross Border Investment Plans
Stocks in China and Hong Kong Jump on Cross Border Investment Plans
Alcoa Shares Increase After Earnings Beat Estimates
Alcoa Shares Increase After Earnings Beat Estimates


Leave a Reply

 
 
© 2006-2014 Ticker Report. Google+. Subscribe